Literature DB >> 11750098

Circulating PIG-A mutant T lymphocytes in healthy adults and patients with bone marrow failure syndromes.

R E Ware1, C V Pickens, C M DeCastro, T A Howard.   

Abstract

OBJECTIVE: Paroxysmal nocturnal hemoglobinuria (PNH) is a clonal hematological disorder with acquired PIG-A gene mutations and absent surface expression of proteins utilizing glycosylphosphatidylinositol (GPI) anchors. PNH often follows aplastic anemia, suggesting PIG-A mutant cells have relative dominance over normal hematopoietic cells. Somatic PIG-A mutations could arise after aplasia, or healthy persons could have rare PIG-A mutant cells that expand under selection pressure.
METHODS: We developed an in vitro negative selection method to isolate GPI-deficient T lymphocytes using aerolysin, an Aeromonas toxin that binds GPI anchors and induces cell lysis. Peripheral blood mononuclear cells (PBMC) from normal adults and patients with PNH or other bone marrow failure syndromes were analyzed.
RESULTS: From healthy adults, 166 T lymphocyte clones with deficient GPI-linked surface protein expression (CD55, CD59) were isolated. The mean mutant frequency (M(f)) of aerolysin-resistant clones was 17.8 +/- 13.8 per 10(6) PBMC, range 5.0-59.6 per 10(6) cells. Clones had a Class A complementation defect and distinct PIG-A mutations. Patients with PNH had elevated aerolysin-resistant M(f) values averaging 19 x 10(-2), a 10,000-fold difference. Two patients with Fanconi anemia and two others with mild aplastic anemia had M(f) values less than 15 x 10(-6), but two with recovering aplastic anemia had M(f) values of 20 x 10(-4), representing an intermediate value between normal persons and PNH patients.
CONCLUSION: Identification of PIG-A mutant T lymphocytes in healthy adults suggests PNH could develop following intense negative selection of hematopoiesis, with clonal outgrowth of naturally occurring PIG-A mutant stem cells.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11750098     DOI: 10.1016/s0301-472x(01)00746-9

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  12 in total

1.  Mutation in PIGA results in a CD52-negative escape variant in a Sézary syndrome patient during alemtuzumab treatment.

Authors:  Constantijn J M Halkes; Willem H Zoutman; Leslie van der Fits; Inge Jedema; Maarten H Vermeer
Journal:  J Invest Dermatol       Date:  2014-11-28       Impact factor: 8.551

2.  CRISPR/Cas9 PIG -A gene editing in nonhuman primate model demonstrates no intrinsic clonal expansion of PNH HSPCs.

Authors:  Tae-Hoon Shin; Eun Jung Baek; Marcus A F Corat; Shirley Chen; Jean-Yves Metais; Aisha A AlJanahi; Yifan Zhou; Robert E Donahue; Kyung-Rok Yu; Cynthia E Dunbar
Journal:  Blood       Date:  2019-04-19       Impact factor: 22.113

3.  PIG-A mutations in normal hematopoiesis.

Authors:  Rong Hu; Galina L Mukhina; Steven Piantadosi; Jamie P Barber; Richard J Jones; Robert A Brodsky
Journal:  Blood       Date:  2005-02-01       Impact factor: 22.113

4.  Unusual association between increased bone resorption and presence of paroxysmal nocturnal hemoglobinuria phenotype in multiple myeloma.

Authors:  Evangelos Terpos; Michalis Samarkos; Christos Meletis; Effie Apostolidou; Maria Tsironi; Konstantinos Korovesis; Despina Mavrogianni; Nora Viniou; John Meletis
Journal:  Int J Hematol       Date:  2003-11       Impact factor: 2.490

5.  Spontaneously arising red cells with a McLeod-like phenotype in normal donors.

Authors:  David J Araten; Katie J Sanders; Jeffrey Pu; Soohee Lee
Journal:  Mutat Res       Date:  2009-04-02       Impact factor: 2.433

6.  How I treat paroxysmal nocturnal hemoglobinuria.

Authors:  Robert A Brodsky
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

7.  A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene.

Authors:  David J Araten; Jose A Martinez-Climent; Mary Ann Perle; Eliana Holm; Leah Zamechek; Kimberly DiTata; Katie J Sanders
Journal:  Mutat Res       Date:  2010-01-08       Impact factor: 2.433

8.  Glycosylphosphatidylinositol-anchored protein deficiency confers resistance to apoptosis in PNH.

Authors:  William J Savage; James P Barber; Galina L Mukhina; Rong Hu; Guibin Chen; William Matsui; Chris Thoburn; Allan D Hess; Linzhao Cheng; Richard J Jones; Robert A Brodsky
Journal:  Exp Hematol       Date:  2008-11-14       Impact factor: 3.084

9.  Leukemic blasts with the paroxysmal nocturnal hemoglobinuria phenotype in children with acute lymphoblastic leukemia.

Authors:  David J Araten; Katie J Sanders; Dan Anscher; Leah Zamechek; Stephen P Hunger; Sherif Ibrahim
Journal:  Am J Pathol       Date:  2012-08-30       Impact factor: 4.307

10.  Silencing of genes required for glycosylphosphatidylinositol anchor biosynthesis in Burkitt lymphoma.

Authors:  Rong Hu; Galina L Mukhina; Soo Hee Lee; Richard J Jones; Paul T Englund; Patrick Brown; Saul J Sharkis; J Thomas Buckley; Robert A Brodsky
Journal:  Exp Hematol       Date:  2009-04       Impact factor: 3.084

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.